Mackenzie Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $982K | Buy |
|
|||||
|
2025
Q2 | $954K | Sell |
|
|||||
|
2025
Q1 | $872K | Buy |
|
|||||
|
2024
Q4 | $637K | Buy |
|
|||||
|
2024
Q3 | $221K | Buy |
|
|||||
|
2024
Q2 | $173K | Sell |
|
|||||
|
2024
Q1 | $164K | Buy |
|
|||||
|
2023
Q4 | $140K | Buy |
|
|||||
|
2023
Q3 | $86.1K | Sell |
|
|||||
|
2023
Q2 | $367K | Sell |
|
|||||
|
2023
Q1 | $491K | Buy |
|
|||||
|
2022
Q4 | $245K | Sell |
|
|||||
|
2022
Q3 | $663K | Buy |
|
|||||
|
2022
Q2 | $250K | Buy |
|
|||||
|
2022
Q1 | $290K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $150K | Buy |
|